Gossamer Bio

About:

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Website: https://www.gossamerbio.com

Twitter/X: gossamerbio

Top Investors: MidCap Financial, Polaris Partners, New Enterprise Associates, Invus, Abu Dhabi Investment Authority

Description:

Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

Total Funding Amount:

$812M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2015-01-01

Contact Email:

PR(AT)GossamerBio.com

Founders:

Faheem Hasnain, Sheila Gujrathi

Number of Employees:

101-250

Last Funding Date:

2023-07-20

IPO Status:

Public

© 2025 bioDAO.ai